Researchers have discovered a molecule found in frog skin that could offer a promising new treatment option for type 2 diabetes. Combining the frog skin molecule with a component of an existing type 2 diabetes drug boosted insulin production and improved glucose tolerance in mice. The GLP-1 group of type 2 diabetes drugs are based on molecules found in animal venom, and skin secretions from frogs are also known to have insulin-stimulating properties. Further research is needed to determine whether this new treatment is safe and effective in humans.
